Patents by Inventor Mark J. Krantz

Mark J. Krantz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccine for modulating between T1 and T2 immune responses
    Patent number: 8552145
    Abstract: The present invention provides liposomal vaccines containing immunogenic lipopeptides that are capable of modulating the humoral and cellular immune responses in vivo.
    Type: Grant
    Filed: May 2, 2012
    Date of Patent: October 8, 2013
    Assignee: Oncothyreon Inc.
    Inventors: Wladyslaw A. Budzynski, R. Rao Koganty, Mark J. Krantz, B. Michael Longenecker
  • Vaccine for Modulating Between T1 and T2 Immune Responses
    Publication number: 20120269885
    Abstract: The present invention provides liposomal vaccines containing immunogenic lipopeptides that are capable of modulating the humoral and cellular immune responses in vivo.
    Type: Application
    Filed: May 2, 2012
    Publication date: October 25, 2012
    Inventors: Wladyslaw A. Budzynski, R. Rao Koganty, Mark J. Krantz, B. Michael Longenecker
  • Vaccine for Modulating Between T1 and T2 Immune Responses
    Publication number: 20120269884
    Abstract: The present invention provides liposomal vaccines containing immunogenic lipopeptides that are capable of modulating the humoral and cellular immune responses in vivo.
    Type: Application
    Filed: May 2, 2012
    Publication date: October 25, 2012
    Inventors: Wladyslaw A. Budzynski, R. Rao Koganty, Mark J. Krantz, B. Michael Longenecker
  • Vaccine for modulating between T1 and T2 immune responses
    Patent number: 8198400
    Abstract: The present invention provides liposomal vaccines containing immunogenic lipopeptides that are capable of modulating the humoral and cellular immune responses in vivo.
    Type: Grant
    Filed: March 27, 2002
    Date of Patent: June 12, 2012
    Assignee: Oncothyreon, Inc.
    Inventors: Wladyslaw A. Budzynski, R. Rao Koganty, Mark J. Krantz, B. Michael Longenecker
  • Vaccine for modulating between T1 and T2 immune responses
    Publication number: 20030157160
    Abstract: The present invention provides liposomal vaccines containing immunogenic lipopeptides that are capable of modulating the humoral and cellular immune responses in vivo.
    Type: Application
    Filed: March 27, 2002
    Publication date: August 21, 2003
    Applicant: BIOMIRA, INC.
    Inventors: Wladyslaw A. Budzynski, R. Rao Koganty, Mark J. Krantz, B. Michael Longenecker
  • Lipid-modified muc-1 derivatives
    Patent number: 6600012
    Abstract: A method for generating a mixture of activated T-cells by combining a plurality of peripheral blood lymphocytes (PBLs) with an antigen-loaded liposome to produce antigen-loaded PBLs, and combining the antigen-loaded PBLs with a naive, anergic or memory T-cell, to produce an activated T-cell. Such activation is carried out in vivo or in vitro. The antigen-loaded PBLs and activated T-cells, prepared according to the methods of invention, have use as cellular vaccines for treatment of cancer and viral diseases.
    Type: Grant
    Filed: February 3, 2000
    Date of Patent: July 29, 2003
    Assignee: Biomira, Inc.
    Inventors: Babita Agrawal, Mark J. Krantz, Mark A. Reddish, B. Michael Longenecker